ChemDiv shares an update on its Cutting-edge Biology Facility in Portugal

ChemDiv, a prominent global contract research organization (CRO), has recently shared an update on its cutting-edge biology facility located in Portugal. This facility is part of ChemDiv’s commitment to providing advanced drug discovery services to clients within the pharmaceutical and biotech industries worldwide.

Key points to note about the facility are as follows:

State-of-the-art infrastructure and equipment

The newly-built facility boasts a world-class infrastructure spanning over 3,000 square meters. It has been equipped with cutting-edge technologies and specialized equipment to cater to a wide range of services such as assay development, high-throughput screening, hit identification and profiling, pharmacology, and discovery biology. By incorporating the latest advancements in automation, bioinformatics, and screening technologies, the facility ensures high-quality data and rapid results delivery.

Expert team of scientists

At the heart of this cutting-edge facility is a highly skilled and experienced team of scientists specializing in various aspects of drug discovery. These scientists possess a wealth of expertise in assay development, high-throughput screening, pharmacology, and medicinal chemistry. With their extensive industry knowledge and successful track records in drug discovery programs, they are well-positioned to collaborate closely with clients and meet their specific requirements.

Fostering innovation and collaboration

The facility has been meticulously designed to foster innovation and collaboration. With its flexible infrastructure, it can be customized to accommodate a myriad of client needs. ChemDiv’s scientists actively engage with clients to gain a deep understanding of their unique program requirements, enabling them to tailor their services accordingly. Furthermore, clients can gain access to ChemDiv’s extensive compound collection, comprising over 1 million compounds, providing additional support for their drug discovery endeavors.

Emphasis on quality and data integrity

Quality is a top priority at ChemDiv’s biology facility. Rigorous quality control measures and constant monitoring procedures are in place to ensure data integrity. The highly trained technicians adhere to the highest standards of best practice, cementing the facility’s reputation as a reliable provider of high-quality data.

In conclusion, ChemDiv’s biology facility in Portugal represents a significant investment in infrastructure and expertise. It serves as a testament to the company’s commitment to innovation, collaboration, and delivering exceptional drug discovery services. With its state-of-the-art technology, expert scientists, and emphasis on quality, the facility is positioned to help clients accelerate their drug discovery programs and bring novel therapies to patients worldwide.